An international honor headed to Houston's Dr John Mendelsohn, former president of MD

Anderson Cancer Center. It's called the Tang Prize in Biopharmaceutical Science...and

credits Mendelsohn for launching the field of targeted therapy that is now prolonging and

saving lives.

The award cites Dr Mendelsohn for leading the way in developing antibodies to block cancer

growth and applying it individually to patients. It has led to fundamentally changing the

practices of cancer clinics.

Think of it as great advancement in battling a world-wide scourge.

And he’s still in the fight. Dr Mendelsohn remains a professor in genomics and personalized

cancer treatment at MD Anderson and is a Senior Fellow at Rice University’s Baker Institute.

Shara Fryer

Shara Fryer

Want to know more about Shara Fryer? Get her official bio, social pages & articles on KTRH! Read more


Content Goes Here